WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2009141573) NOVEL POLYMORPH OF TEGASEROD ADIPATE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2009/141573    International Application No.:    PCT/GB2008/051128
Publication Date: 26.11.2009 International Filing Date: 27.11.2008
IPC:
C07D 209/14 (2006.01), A61K 31/404 (2006.01), A61P 1/00 (2006.01)
Applicants: GENERICS [UK] LIMITED [GB/GB]; Albany Gate Darkes Lane Potters Bar Hertfordshire EN6 1AG (GB) (For All Designated States Except US).
MYLAN DEVELOPMENT CENTRE PRIVATE LIMITED [IN/IN]; Plot 1 A/2, M.I.D.C. Industrial Estate, Taloja, Panvel 410 208, District Raigad, Maharashtra (IN) (For All Designated States Except US).
GAITONDE, Abhay [IN/IN]; (IN) (For US Only).
MANOJKUMAR, Bindu [IN/IN]; (IN) (For US Only).
PHADTARE, Sunanda [IN/IN]; (IN) (For US Only).
TANK, Sinderpal [IN/IN]; (IN) (For US Only)
Inventors: GAITONDE, Abhay; (IN).
MANOJKUMAR, Bindu; (IN).
PHADTARE, Sunanda; (IN).
TANK, Sinderpal; (IN)
Agent: ELEND, Almut; Venner Shipley LLP Byron House Cambridge Business Park Cowley Road Cambridge, Cambridgeshire CB4 0WZ (GB)
Priority Data:
912/KOL/2008 21.05.2008 IN
Title (EN) NOVEL POLYMORPH OF TEGASEROD ADIPATE
(FR) NOUVEAU POLYMORPHE D'ADIPATE DE TEGASEROD
Abstract: front page image
(EN)The present invention relates to a novel crystalline form of tegaserod adipate and to processes for preparing said form. The invention also relates to pharmaceutical compositions comprising said crystalline form and to the use of said compositions in the treatment of gastrointestinal disorders, in particular irritable bowel syndrome.
(FR)La présente invention concerne une nouvelle forme cristalline d'adipate de tegaserod ainsi que des procédés permettant de les préparer. L'invention concerne également des compositions pharmaceutiques comprenant cette forme cristalline ainsi que l'utilisation de ces compositions pour le traitement de troubles gastro-intestinaux, en particulier le syndrome du côlon irritable.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)